Brachytherapy, ISSN 1538-4721, 2016, Volume 16, Issue 2, pp. 245 - 265
Abstract Purpose Prostate brachytherapy (PB) has well-documented excellent long-term outcomes in all risk groups. There are significant uncertainties regarding...
Radiology | Hematology, Oncology and Palliative Medicine | CSS | Brachytherapy | Androgen deprivation therapy | Prostate cancer | bPFS | Outcomes | TROG 03.04 RADAR | INTERMEDIATE-RISK | INTERSTITIAL BRACHYTHERAPY | CARDIOVASCULAR MORBIDITY | CANCER-SPECIFIC MORTALITY | ONCOLOGY | LONG-TERM IMPACT | HIGH-RISK | EXTERNAL-BEAM RADIATION | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HORMONAL-THERAPY | Radiotherapy Dosage | Disease-Free Survival | Humans | Risk Factors | Brachytherapy - methods | Androgen Antagonists - therapeutic use | Male | Treatment Outcome | Combined Modality Therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - therapy | Task forces | Usage | Radioisotope brachytherapy | Medicine, Experimental | Medical research
Radiology | Hematology, Oncology and Palliative Medicine | CSS | Brachytherapy | Androgen deprivation therapy | Prostate cancer | bPFS | Outcomes | TROG 03.04 RADAR | INTERMEDIATE-RISK | INTERSTITIAL BRACHYTHERAPY | CARDIOVASCULAR MORBIDITY | CANCER-SPECIFIC MORTALITY | ONCOLOGY | LONG-TERM IMPACT | HIGH-RISK | EXTERNAL-BEAM RADIATION | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HORMONAL-THERAPY | Radiotherapy Dosage | Disease-Free Survival | Humans | Risk Factors | Brachytherapy - methods | Androgen Antagonists - therapeutic use | Male | Treatment Outcome | Combined Modality Therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms - therapy | Task forces | Usage | Radioisotope brachytherapy | Medicine, Experimental | Medical research
Journal Article
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, ISSN 0889-8588, 12/2019, Volume 33, Issue 6, pp. 1011 - 1011
Brachytherapy involves the placement of radioactive sources within or very close to the tumor. This placement allows a high dose of radiotherapy to be...
Rectal cancer | LOCALIZED PROSTATE-CANCER | CERVIX CANCER BRACHYTHERAPY | AMERICAN BRACHYTHERAPY | Breast cancer | HIGH-DOSE-RATE | Skin cancer | IMAGE-GUIDED BRACHYTHERAPY | PARTIAL BREAST IRRADIATION | Radionuclide | INTERSTITIAL MULTICATHETER BRACHYTHERAPY | RECTAL-CANCER | ONCOLOGY | Normal tissue sparing | Cervix cancer | EXTERNAL-BEAM RADIATION | Brachytherapy | HEMATOLOGY | Prostate cancer | IN-SITU CARCINOMA
Rectal cancer | LOCALIZED PROSTATE-CANCER | CERVIX CANCER BRACHYTHERAPY | AMERICAN BRACHYTHERAPY | Breast cancer | HIGH-DOSE-RATE | Skin cancer | IMAGE-GUIDED BRACHYTHERAPY | PARTIAL BREAST IRRADIATION | Radionuclide | INTERSTITIAL MULTICATHETER BRACHYTHERAPY | RECTAL-CANCER | ONCOLOGY | Normal tissue sparing | Cervix cancer | EXTERNAL-BEAM RADIATION | Brachytherapy | HEMATOLOGY | Prostate cancer | IN-SITU CARCINOMA
Journal Article
Brachytherapy, ISSN 1538-4721, 2013, Volume 12, Issue 3, pp. 191 - 198
Abstract Purpose To develop a consensus statement between the American Brachytherapy Society (ABS) and Groupe Européen de Curiethérapie/European Society for...
Radiology | Hematology, Oncology and Palliative Medicine | Pulse-dose-rate brachytherapy | High-dose-rate brachytherapy | Low-dose-rate brachytherapy | Penile carcinoma | Interstitial brachytherapy | CIRCUMCISION | FOLLOW-UP | CANCER | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | EXPERIENCE | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Societies, Medical | United States | Europe | Humans | Brachytherapy - standards | Male | Penile Neoplasms - radiotherapy | Radiation Oncology | Consensus | Practice Guidelines as Topic | Radioisotope brachytherapy | Health aspects | Trade and professional associations
Radiology | Hematology, Oncology and Palliative Medicine | Pulse-dose-rate brachytherapy | High-dose-rate brachytherapy | Low-dose-rate brachytherapy | Penile carcinoma | Interstitial brachytherapy | CIRCUMCISION | FOLLOW-UP | CANCER | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | EXPERIENCE | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Societies, Medical | United States | Europe | Humans | Brachytherapy - standards | Male | Penile Neoplasms - radiotherapy | Radiation Oncology | Consensus | Practice Guidelines as Topic | Radioisotope brachytherapy | Health aspects | Trade and professional associations
Journal Article
Brachytherapy, ISSN 1538-4721, 07/2019, Volume 18, Issue 4, pp. 429 - 436
The purpose of this study was to report a list of accepted fractionation schemes for high-dose-rate (HDR) brachytherapy for gynecological cancers in a...
Fractionation | Brachytherapy | Gynecological cancer | Consensus | GUIDED ADAPTIVE BRACHYTHERAPY | ADJUVANT VAGINAL BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ENDOMETRIAL CANCER | CONSENSUS GUIDELINES | EXTERNAL-BEAM RADIOTHERAPY | ADVANCED CERVICAL-CANCER | ONCOLOGY | PREOPERATIVE RADIATION-THERAPY | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LOCALLY ADVANCED-CARCINOMA | Radioisotope brachytherapy | Task forces | Medical societies
Fractionation | Brachytherapy | Gynecological cancer | Consensus | GUIDED ADAPTIVE BRACHYTHERAPY | ADJUVANT VAGINAL BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ENDOMETRIAL CANCER | CONSENSUS GUIDELINES | EXTERNAL-BEAM RADIOTHERAPY | ADVANCED CERVICAL-CANCER | ONCOLOGY | PREOPERATIVE RADIATION-THERAPY | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LOCALLY ADVANCED-CARCINOMA | Radioisotope brachytherapy | Task forces | Medical societies
Journal Article
1988, ISBN 9780023547706, x, 326
Book
Advanced Drug Delivery Reviews, ISSN 0169-409X, 01/2017, Volume 109, pp. 15 - 25
Brachytherapy is a radiotherapy modality associated with a highly focal dose distribution. Brachytherapy treats the cancer tissue from the inside, and the...
Hypofractionation | Image guided therapy | Technology | Imaging | Brachytherapy | Radiotherapy | Focal therapy | COST-EFFECTIVENESS | LOCALIZED PROSTATE-CANCER | GUIDED ADAPTIVE BRACHYTHERAPY | CERVIX CANCER BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | HIGH-DOSE-RATE | RADIATION-THERAPY | WHOLE-BREAST IRRADIATION | GEC-ESTRO | EXTERNAL-BEAM RADIOTHERAPY | PHARMACOLOGY & PHARMACY | Diagnostic Imaging | Brachytherapy - trends | Imaging, Three-Dimensional | Humans | Brachytherapy - methods | Radioisotope brachytherapy | Medical colleges | CT imaging
Hypofractionation | Image guided therapy | Technology | Imaging | Brachytherapy | Radiotherapy | Focal therapy | COST-EFFECTIVENESS | LOCALIZED PROSTATE-CANCER | GUIDED ADAPTIVE BRACHYTHERAPY | CERVIX CANCER BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | HIGH-DOSE-RATE | RADIATION-THERAPY | WHOLE-BREAST IRRADIATION | GEC-ESTRO | EXTERNAL-BEAM RADIOTHERAPY | PHARMACOLOGY & PHARMACY | Diagnostic Imaging | Brachytherapy - trends | Imaging, Three-Dimensional | Humans | Brachytherapy - methods | Radioisotope brachytherapy | Medical colleges | CT imaging
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 231 - 238
Abstract Objective Since the Group Européen de Curiethérapie and the European Society for Radiotherapy and Oncology (GEC–ESTRO) published recommendations for...
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Image-guided brachytherapy | GEC–ESTRO guidelines | Primary chemoradiation | Radiotherapy | Survival | Cervical cancer | GEC-ESTRO guidelines | TANDEM-OVOID APPLICATORS | PARAMETERS | INTRACAVITARY BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ADAPTIVE BRACHYTHERAPY | OBSTETRICS & GYNECOLOGY | VIENNA APPLICATOR | PDR BRACHYTHERAPY | ONCOLOGY | RECOMMENDATIONS | PROGNOSTIC-FACTOR ANALYSES | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Adenosquamous - drug therapy | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - radiotherapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Imaging, Three-Dimensional | Adenocarcinoma - radiotherapy | Carcinoma, Adenosquamous - pathology | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Neoplasm Recurrence, Local | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Disease-Free Survival | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Radiotherapy, Image-Guided - methods | Aged | Neoplasm Staging | Cancer patients | Care and treatment | Radioisotope brachytherapy | Comparative analysis | Patient outcomes
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Image-guided brachytherapy | GEC–ESTRO guidelines | Primary chemoradiation | Radiotherapy | Survival | Cervical cancer | GEC-ESTRO guidelines | TANDEM-OVOID APPLICATORS | PARAMETERS | INTRACAVITARY BRACHYTHERAPY | INTERSTITIAL BRACHYTHERAPY | ADAPTIVE BRACHYTHERAPY | OBSTETRICS & GYNECOLOGY | VIENNA APPLICATOR | PDR BRACHYTHERAPY | ONCOLOGY | RECOMMENDATIONS | PROGNOSTIC-FACTOR ANALYSES | Adenocarcinoma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Adenosquamous - drug therapy | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - radiotherapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Imaging, Three-Dimensional | Adenocarcinoma - radiotherapy | Carcinoma, Adenosquamous - pathology | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Neoplasm Recurrence, Local | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Disease-Free Survival | Magnetic Resonance Imaging | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Radiotherapy, Image-Guided - methods | Aged | Neoplasm Staging | Cancer patients | Care and treatment | Radioisotope brachytherapy | Comparative analysis | Patient outcomes
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 12/2018, Volume 129, Issue 3, pp. 567 - 574
To investigate the isodose surface volumes ( ) for 85, 75 and 60 Gy EQD2 for locally advanced cervix cancer patients. 1201 patients accrued in the EMBRACE I...
Isodose surface volume | Magnetic resonance image guided brachytherapy | Point A | Standard loading brachytherapy | Cervical cancer | TRAK | PARAMETERS | INTERSTITIAL BRACHYTHERAPY | VIENNA APPLICATOR | COMBINED INTRACAVITARY | REPAIR | IMPACT | ONCOLOGY | IMPROVES | OPTIMIZATION | brachytherapy | RADIOTHERAPY | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Magnetic resonance image guided | Radioisotope brachytherapy | Analysis | Cancer
Isodose surface volume | Magnetic resonance image guided brachytherapy | Point A | Standard loading brachytherapy | Cervical cancer | TRAK | PARAMETERS | INTERSTITIAL BRACHYTHERAPY | VIENNA APPLICATOR | COMBINED INTRACAVITARY | REPAIR | IMPACT | ONCOLOGY | IMPROVES | OPTIMIZATION | brachytherapy | RADIOTHERAPY | DOSE-RATE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Magnetic resonance image guided | Radioisotope brachytherapy | Analysis | Cancer
Journal Article
Brachytherapy, ISSN 1538-4721, 2016, Volume 16, Issue 1, pp. 1 - 12
Abstract Purpose To review outcomes for high-risk prostate cancer treated with combined modality radiation therapy (CMRT) utilizing external beam radiation...
Radiology | Hematology, Oncology and Palliative Medicine | Prostate cancer therapy | High-risk prostate cancer | Combination brachytherapy and external beam radiation | INTENSITY-MODULATED BRACHYTHERAPY | LONG-TERM OUTCOMES | RADICAL PROSTATECTOMY | INTERSTITIAL BRACHYTHERAPY | BIOCHEMICAL OUTCOMES | HIGH-DOSE-RATE | ANDROGEN-DEPRIVATION THERAPY | CONSENSUS GUIDELINES | ONCOLOGY | GLEASON PATTERN 5 | ADJUVANT RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | United States | Humans | Brachytherapy - methods | Male | Survival Rate | Combined Modality Therapy | Prostate-Specific Antigen - blood | Advisory Committees | Disease-Free Survival | Societies, Medical | Radiotherapy - methods | Androgen Antagonists - therapeutic use | Prostatic Neoplasms - blood | Retrospective Studies | Radiation Oncology | Prostatic Neoplasms - drug therapy | Medical colleges | Task forces | Radioisotope brachytherapy | Health aspects | Prostate cancer | Risk factors | Index Medicus
Radiology | Hematology, Oncology and Palliative Medicine | Prostate cancer therapy | High-risk prostate cancer | Combination brachytherapy and external beam radiation | INTENSITY-MODULATED BRACHYTHERAPY | LONG-TERM OUTCOMES | RADICAL PROSTATECTOMY | INTERSTITIAL BRACHYTHERAPY | BIOCHEMICAL OUTCOMES | HIGH-DOSE-RATE | ANDROGEN-DEPRIVATION THERAPY | CONSENSUS GUIDELINES | ONCOLOGY | GLEASON PATTERN 5 | ADJUVANT RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | United States | Humans | Brachytherapy - methods | Male | Survival Rate | Combined Modality Therapy | Prostate-Specific Antigen - blood | Advisory Committees | Disease-Free Survival | Societies, Medical | Radiotherapy - methods | Androgen Antagonists - therapeutic use | Prostatic Neoplasms - blood | Retrospective Studies | Radiation Oncology | Prostatic Neoplasms - drug therapy | Medical colleges | Task forces | Radioisotope brachytherapy | Health aspects | Prostate cancer | Risk factors | Index Medicus
Journal Article
Medical Physics, ISSN 0094-2405, 10/2012, Volume 39, Issue 10, pp. 6208 - 6236
The charge of Task Group 186 (TG-186) is to provide guidance for early adopters of model-based dose calculation algorithms (MBDCAs) for brachytherapy (BT) dose...
heterogeneities | treatment planning | dose scoring | dose calculation | brachytherapy | radiation transport | commissioning | material assignments | Segmentation | sensitivity analysis | Cell nucleus | Tissues | Digital computing or data processing equipment or methods, specially adapted for specific applications | Monte Carlo methods | Computed tomography | feature extraction | image segmentation | Dosimetry | Computerised tomographs | medical image processing | photoelectricity | Medical imaging | biological tissues | Photons | Radiation therapy | Infrared sources | Dose‐volume analysis | computerised tomography | Image data processing or generation, in general | Therapeutic applications, including brachytherapy | Dosimetry/exposure assessment | LOW-ENERGY BRACHYTHERAPY | IMAGE-GUIDED RADIOTHERAPY | I-125 INTERSTITIAL-BRACHYTHERAPY | BEAM COMPUTED-TOMOGRAPHY | COLLAPSED CONE SUPERPOSITION | TREATMENT PLANNING SYSTEMS | BOLTZMANN-EQUATION SOLVER | MONTE-CARLO CALCULATIONS | PERMANENT PROSTATE IMPLANTS | EYE PLAQUE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Humans | Iridium Radioisotopes - therapeutic use | Brachytherapy - methods | Radiation Dosage | Ytterbium - therapeutic use | Cone-Beam Computed Tomography | Artifacts | Algorithms | Models, Biological | Research Report | Phantoms, Imaging | Monte Carlo Method | PATIENTS | CALCULATION METHODS | RADIATION PROTECTION AND DOSIMETRY | VALIDATION | RADIATION DOSES | ALGORITHMS | COMPUTERIZED TOMOGRAPHY | ACCURACY | PLANNING | PHOTOELECTRIC EFFECT | CROSS SECTIONS | IMAGE PROCESSING | RADIATION DOSE DISTRIBUTIONS | RECOMMENDATIONS | RADIOLOGY AND NUCLEAR MEDICINE | ELECTRON DENSITY | ICRP | BRACHYTHERAPY | DOSIMETRY | ENERGY DEPENDENCE | ICRU | WATER | Annan fysik | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences | Other Physics Topics
heterogeneities | treatment planning | dose scoring | dose calculation | brachytherapy | radiation transport | commissioning | material assignments | Segmentation | sensitivity analysis | Cell nucleus | Tissues | Digital computing or data processing equipment or methods, specially adapted for specific applications | Monte Carlo methods | Computed tomography | feature extraction | image segmentation | Dosimetry | Computerised tomographs | medical image processing | photoelectricity | Medical imaging | biological tissues | Photons | Radiation therapy | Infrared sources | Dose‐volume analysis | computerised tomography | Image data processing or generation, in general | Therapeutic applications, including brachytherapy | Dosimetry/exposure assessment | LOW-ENERGY BRACHYTHERAPY | IMAGE-GUIDED RADIOTHERAPY | I-125 INTERSTITIAL-BRACHYTHERAPY | BEAM COMPUTED-TOMOGRAPHY | COLLAPSED CONE SUPERPOSITION | TREATMENT PLANNING SYSTEMS | BOLTZMANN-EQUATION SOLVER | MONTE-CARLO CALCULATIONS | PERMANENT PROSTATE IMPLANTS | EYE PLAQUE BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Uncertainty | Radiotherapy Planning, Computer-Assisted - methods | Humans | Iridium Radioisotopes - therapeutic use | Brachytherapy - methods | Radiation Dosage | Ytterbium - therapeutic use | Cone-Beam Computed Tomography | Artifacts | Algorithms | Models, Biological | Research Report | Phantoms, Imaging | Monte Carlo Method | PATIENTS | CALCULATION METHODS | RADIATION PROTECTION AND DOSIMETRY | VALIDATION | RADIATION DOSES | ALGORITHMS | COMPUTERIZED TOMOGRAPHY | ACCURACY | PLANNING | PHOTOELECTRIC EFFECT | CROSS SECTIONS | IMAGE PROCESSING | RADIATION DOSE DISTRIBUTIONS | RECOMMENDATIONS | RADIOLOGY AND NUCLEAR MEDICINE | ELECTRON DENSITY | ICRP | BRACHYTHERAPY | DOSIMETRY | ENERGY DEPENDENCE | ICRU | WATER | Annan fysik | Fysik | Physical Sciences | Naturvetenskap | Natural Sciences | Other Physics Topics
Journal Article